España
Acceder
Cotización de Crinetics Pharmaceuticals, Inc. (CRNX) hoy en tiempo real
Análisis técnico y gráfico histórico de Crinetics Pharmaceuticals, Inc.
Análisis fundamental y estadísticas clave de Crinetics Pharmaceuticals, Inc.
Ficha de Crinetics Pharmaceuticals, Inc. (CRNX)
| Ticker | CRNX |
|---|---|
| ISIN | US22663K1079 |
| Sector | Atención sanitaria |
| Mercado | NASDAQ |
Análisis financiero de Crinetics Pharmaceuticals, Inc.
Resumen financiero e información corporativa de Crinetics Pharmaceuticals, Inc.
Ratios de valoración: PER, EV/EBITDA y métricas de Crinetics Pharmaceuticals, Inc.
Márgenes de rentabilidad y Cash Flow de Crinetics Pharmaceuticals, Inc.
BPA, Dividendos y Valor Contable: Métricas por acción de Crinetics Pharmaceuticals, Inc.
Solvencia y deuda: Análisis del balance de Crinetics Pharmaceuticals, Inc.
Ratios de liquidez y Test Ácido: Capacidad de pago de Crinetics Pharmaceuticals, Inc.
Invertir en Crinetics Pharmaceuticals, Inc. en 2026: Preguntas frecuentes
¿Qué es Crinetics Pharmaceuticals, Inc.?
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III clinical trial for the treatment of acromegaly, as well as completed phase II clinical trial to treat carcinoid syndrome and nonfunctional neuroendocr...
¿En qué sector opera Crinetics Pharmaceuticals, Inc.?
Crinetics Pharmaceuticals, Inc. opera en el sector Healthcare, industria Biotechnology.